Philips (NYSE:PHG) today introduced Rembra, its next-generation radiology computed tomography (CT) imaging system.

Benefits include reduced radiation exposure, fewer adverse reactions, higher image quality, and better detection of malignant features.

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...

CE Marked and 510(k) pending, Philips says Rembra’s advanced image reconstruction technology delivers up to 106 images per second and a high throughput of up to 270 patients per day [2] to support ...